Regeneron Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (76)

Latest Posts

About This Stock More About This Stock
E HH Review Of Present Therapies For Covid-19
Article By: Ketan Desai
Sunday, May 9, 2021 6:28 PM EDT
A summary of authorized drugs for Covid-19, those in development, and those that have failed.
In this article: LLY, MRK, CYDY, REGN, HGEN, RLFTF
Read
3 Cathie Wood Healthcare Stocks To Add To Your Portfolio
Article By: StockNews
Saturday, April 24, 2021 7:40 PM EDT
Despite generating lean capital gains on her holdings in the healthcare industry, Cathie Wood has maintained her positions because she expects genomics to emerge as the next big sector in 2021 that could deliver electric vehicle-like gains.
In this article: NVS, REGN, VRTX Also: ARKG
Read
4 Undervalued Stocks To Watch In April
Article By: Benzinga
Sunday, April 11, 2021 12:31 PM EDT
EBay Inc, SunPower Corporation, Regeneron Pharmaceuticals Inc and Tupperware Brands Corporation​​​​​​​ are four stocks considered technically undervalued this month.
In this article: TUP, REGN, EBAY, SPWR
Read
3 Stocks To Buy For The Genomic Revolution
Article By: StockNews
Sunday, April 4, 2021 12:21 PM EDT
The top holdings in Cathie Wood's Ark Genomic Revolution ETF include Novartis , Regeneron Pharmaceuticals and Vertex Pharmaceuticals. The actively managed fund has gained more than 180% over the past year.
In this article: NVS, REGN, VRTX, ARKG
Read
My Biotech Investing Advice For 2021
Article By: Marc Lichtenfeld
Tuesday, January 19, 2021 5:05 AM EDT
The J.P. Morgan Healthcare Conference is the most important healthcare investment conference of the year.
In this article: FOLD, NVAX, REGN, TGTX Also: JPM
Read

Latest Tweets for $REGN

No tweets yet!

$REGN

Regeneron Pharmaceuticals’ Dupixent Has Multi-Billion-Dollar Potential: Polen Capital
David J. Tanner 1/31/2018 3:55:05 AM

Note it has only been approved in Japan. And only for those whom existing treatments are ineffective. So that's a MUCH smaller market. How small I don't know. But not enough to make me bite. $REGN

1 to 1 of 1 comments